{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T12:09:42Z","timestamp":1789819782106,"version":"4.0.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21CA305031"],"award-info":[{"award-number":["R21CA305031"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA264488"],"award-info":[{"award-number":["R01CA264488"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biomed Microdevices"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s10544-026-00834-w","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T11:54:42Z","timestamp":1786449282000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Poly(2-oxazoline) micelles for co-delivery of paclitaxel and metronidazole benzoate for dual chemotherapeutic and antibacterial targeting in the tumor microenvironment"],"prefix":"10.1007","volume":"28","author":[{"given":"Alyssa","family":"Holden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hallie","family":"Hutsell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liubov","family":"Palchak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyuan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob D.","family":"Ramsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander V.","family":"Kabanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,11]]},"reference":[{"key":"834_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.00400","volume":"10","author":"J Abed","year":"2020","unstructured":"J. Abed, N. Maalouf, A.L. Manson, A.M. Earl, L. Parhi, J.E.M. Emg\u00e5rd, M. Klutstein, S. Tayeb, G. Almogy, K.A. Atlan, S. Chaushu, E. Israeli, O. Mandelboim, W.S. Garrett, G. Bachrach, Colon cancer-associated Fusobacterium nucleatum may originate from the oral cavity and reach colon tumors via the circulatory system. Front. Cell. Infect. Microbiol. 10, 400 (2020). https:\/\/doi.org\/10.3389\/fcimb.2020.00400","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"8","key":"834_CR2","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1111\/jphp.13098","volume":"71","author":"MF Attia","year":"2019","unstructured":"M.F. Attia, N. Anton, J. Wallyn, Z. Omran, T.F. Vandamme, An overview of active and passive targeting strategies to improve the nanocarriers efficiency to tumour sites. J. Pharm. Pharmacol. 71(8), 1185\u20131198 (2019). https:\/\/doi.org\/10.1111\/jphp.13098","journal-title":"J. Pharm. Pharmacol."},{"issue":"1","key":"834_CR3","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1186\/s12905-025-03843-8","volume":"25","author":"C Bose","year":"2025","unstructured":"C. Bose, N.G. Uczkowski, K. Sukla, N. Raval, M.M. Haque, Y. Zhang, B. Varma, J.M. Satagopan, Breast cancer and microbiome: a systematic review highlighting challenges for clinical translation. BMC Women\u2019s Health 25(1), 416 (2025). https:\/\/doi.org\/10.1186\/s12905-025-03843-8","journal-title":"BMC Women\u2019s Health"},{"issue":"5","key":"834_CR4","doi-asserted-by":"publisher","first-page":"387","DOI":"10.2165\/00003495-197816050-00002","volume":"16","author":"RN Brogden","year":"1978","unstructured":"R.N. Brogden, R.C. Heel, T.M. Speight, G.S. Avery, Metronidazole in anaerobic infections: a review of its activity, pharmacokinetics and therapeutic use. Drugs 16(5), 387\u2013417 (1978). https:\/\/doi.org\/10.2165\/00003495-197816050-00002","journal-title":"Drugs"},{"issue":"6","key":"834_CR5","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.jmii.2025.05.008","volume":"58","author":"C-M Chang","year":"2025","unstructured":"C.-M. Chang, L.Y. Lam, H.Y.P. Lam, P.-Y. Kao, S.-T. Hsu, W.-J. Wu, K.-C. Chang, C.-Y. Huang, Potential role of intratumoral Fusobacterium nucleatum and interleukin-1 beta in breast cancer cell growth. J. Microbiol. Immunol. Infect. 58(6), 641\u2013651 (2025). https:\/\/doi.org\/10.1016\/j.jmii.2025.05.008","journal-title":"J. Microbiol. Immunol. Infect."},{"issue":"7","key":"834_CR6","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1038\/s41388-019-1084-z","volume":"39","author":"R Cheng","year":"2020","unstructured":"R. Cheng, S. Billet, C. Liu, S. Haldar, D. Choudhury, M. Tripathi, M. Hav, A. Merchant, T. Hu, H. Huang, H. Zhou, N.A. Bhowmick, Periodontal inflammation recruits distant metastatic breast cancer cells by increasing myeloid-derived suppressor cells. Oncogene 39(7), 1543\u20131556 (2020). https:\/\/doi.org\/10.1038\/s41388-019-1084-z","journal-title":"Oncogene"},{"issue":"5","key":"834_CR7","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/bjc.1976.78","volume":"33","author":"JL Foster","year":"1976","unstructured":"J.L. Foster, P.J. Conroy, A.J. Searle, R.L. Willson, Metronidazole (Flagyl): characterization as a cytotoxic drug specific for hypoxic tumour cells. Br. J. Cancer 33(5), 485\u2013490 (1976). https:\/\/doi.org\/10.1038\/bjc.1976.78","journal-title":"Br. J. Cancer"},{"issue":"6230","key":"834_CR8","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1126\/science.aaa4972","volume":"348","author":"WS Garrett","year":"2015","unstructured":"W.S. Garrett, Cancer and the microbiota. Science 348(6230), 80\u201386 (2015). https:\/\/doi.org\/10.1126\/science.aaa4972","journal-title":"Science"},{"key":"834_CR9","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.biomaterials.2016.06.002","volume":"101","author":"Z He","year":"2016","unstructured":"Z. He, X. Wan, A. Schulz, H. Bludau, M.A. Dobrovolskaia, S.T. Stern, S.A. Montgomery, H. Yuan, Z. Li, D. Alakhova, M. Sokolsky, D.B. Darr, C.M. Perou, R. Jordan, R. Luxenhofer, A.V. Kabanov, A high capacity polymeric micelle of paclitaxel: implication of high dose drug therapy to safety and in vivo anti-cancer activity. Biomaterials 101, 296\u2013309 (2016). https:\/\/doi.org\/10.1016\/j.biomaterials.2016.06.002","journal-title":"Biomaterials"},{"key":"834_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/srep30751","volume":"6","author":"TJ Hieken","year":"2016","unstructured":"T.J. Hieken, J. Chen, T.L. Hoskin, M. Walther-Antonio, S. Johnson, S. Ramaker, J. Xiao, D.C. Radisky, K.L. Knutson, K.R. Kalari, J.Z. Yao, L.M. Baddour, N. Chia, A.C. Degnim, The microbiome of aseptically collected human breast tissue in benign and malignant disease. Sci. Rep. 6, 30751 (2016). https:\/\/doi.org\/10.1038\/srep30751","journal-title":"Sci. Rep."},{"issue":"5","key":"834_CR11","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/j.cell.2019.10.028","volume":"179","author":"DP Hollern","year":"2019","unstructured":"D.P. Hollern, N. Xu, A. Thennavan, C. Glodowski, S. Garcia-Recio, K.R. Mott, X. He, J.P. Garay, K. Carey-Ewend, D. Marron, J. Ford, S. Liu, S.C. Vick, M. Martin, J.S. Parker, B.G. Vincent, J.S. Serody, C.M. Perou, B cells and T follicular helper cells mediate response to checkpoint inhibitors in high mutation burden mouse models of breast cancer. Cell 179(5), 1191-1206.e21 (2019). https:\/\/doi.org\/10.1016\/j.cell.2019.10.028","journal-title":"Cell"},{"issue":"2","key":"834_CR12","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/j.1365-2125.1982.tb01962.x","volume":"14","author":"GW Houghton","year":"1982","unstructured":"G.W. Houghton, H.K.L. Hundt, F.O. Muller, R. Templeton, A comparison of the pharmacokinetics of metronidazole in man after oral administration of single doses of benzoylmetronidazole and metronidazole. Br. J. Clin. Pharmacol. 14(2), 201\u2013206 (1982) https:\/\/doi.org\/10.1111\/j.1365-2125.1982.tb01962.x","journal-title":"Br. J. Clin. Pharmacol."},{"key":"834_CR13","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.addr.2020.09.009","volume":"156","author":"D Hwang","year":"2020","unstructured":"D. Hwang, J.D. Ramsey, A.V. Kabanov, Polymeric micelles for the delivery of poorly soluble drugs: from nanoformulation to clinical approval. Adv. Drug Deliv. Rev. 156, 80\u2013118 (2020). https:\/\/doi.org\/10.1016\/j.addr.2020.09.009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"834_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2021.121140","volume":"278","author":"D Hwang","year":"2021","unstructured":"D. Hwang, N. Vinod, S.L. Skoczen, J.D. Ramsey, K.S. Snapp, S.A. Montgomery, M. Wang, C. Lim, J.E. Frank, M. Sokolsky-Papkov, Z. Li, H. Yuan, S.T. Stern, A.V. Kabanov, Bioequivalence assessment of high-capacity polymeric micelle nanoformulation of paclitaxel and Abraxane\u00ae in rodent and non-human primate models using a stable isotope tracer assay. Biomaterials 278, 121140 (2021). https:\/\/doi.org\/10.1016\/j.biomaterials.2021.121140","journal-title":"Biomaterials"},{"issue":"3","key":"834_CR15","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.clinthera.2011.01.022","volume":"33","author":"FGA Jansman","year":"2011","unstructured":"F.G.A. Jansman, A.K.L. Reyners, E.N. van Roon, C.H. Smorenburg, H.H. Helgason, M. le Comte, B.M. Wensveen, A.M.A. van den Tweel, M. de Blois, W. Kwee, A.L. Kerremans, J.R.B.J. Brouwers, Consensus-based evaluation of clinical significance and management of anticancer drug interactions. Clin. Ther. 33(3), 305\u2013314 (2011). https:\/\/doi.org\/10.1016\/j.clinthera.2011.01.022","journal-title":"Clin. Ther."},{"issue":"4","key":"834_CR16","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1007\/s10555-021-10013-3","volume":"40","author":"T Kov\u00e1cs","year":"2021","unstructured":"T. Kov\u00e1cs, E. Mik\u00f3, G. Ujlaki, H. Yousef, V. Csontos, K. Uray, P. Bai, The involvement of oncobiosis and bacterial metabolite signaling in metastasis formation in breast cancer. Cancer Metastasis Rev. 40(4), 1223\u20131249 (2021). https:\/\/doi.org\/10.1007\/s10555-021-10013-3","journal-title":"Cancer Metastasis Rev."},{"issue":"8","key":"834_CR17","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1158\/2326-6066.CIR-19-0616","volume":"8","author":"TS Lau","year":"2020","unstructured":"T.S. Lau, L.K.Y. Chan, G.C.W. Man, C.H. Wong, J.H.S. Lee, S.F. Yim, T.H. Cheung, I.A. McNeish, J. Kwong, Paclitaxel induces immunogenic cell death in ovarian cancer via TLR4\/IKK2\/SNARE-dependent exocytosis. Cancer Immunol. Res. 8(8), 1099\u20131111 (2020). https:\/\/doi.org\/10.1158\/2326-6066.CIR-19-0616","journal-title":"Cancer Immunol. Res."},{"issue":"1","key":"834_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-023-10844-z","volume":"23","author":"G Li","year":"2023","unstructured":"G. Li, Y. Sun, Y. Huang, J. Lian, S. Wu, D. Luo, H. Gong, Fusobacterium nucleatum-derived small extracellular vesicles facilitate tumor growth and metastasis via TLR4 in breast cancer. BMC Cancer 23(1), 473 (2023). https:\/\/doi.org\/10.1186\/s12885-023-10844-z","journal-title":"BMC Cancer"},{"issue":"4","key":"834_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202103552","volume":"18","author":"C Lim","year":"2022","unstructured":"C. Lim, J.D. Ramsey, D. Hwang, S.C.M. Teixeira, C.-D. Poon, J.D. Strauss, E.P. Rosen, M. Sokolsky-Papkov, A.V. Kabanov, Drug-dependent morphological transitions in spherical and worm-like polymeric micelles define stability and pharmacological performance of micellar drugs. Small 18(4), e2103552 (2022). https:\/\/doi.org\/10.1002\/smll.202103552","journal-title":"Small"},{"key":"834_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.nantod.2023.101884","volume":"51","author":"C Lim","year":"2023","unstructured":"C. Lim, D. Hwang, M. Yazdimamaghani, H.M. Atkins, H. Hyun, Y. Shin, J.D. Ramsey, P.D. R\u00e4dler, K.R. Mott, C.M. Perou, M. Sokolsky-Papkov, A.V. Kabanov, High-dose paclitaxel and its combination with CSF1R inhibitor in polymeric micelles for chemoimmunotherapy of triple negative breast cancer. Nano Today 51, 101884 (2023). https:\/\/doi.org\/10.1016\/j.nantod.2023.101884","journal-title":"Nano Today"},{"issue":"1","key":"834_CR21","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1002\/j.1875-9114.1998.tb03830.x","volume":"18","author":"EL Michalets","year":"1998","unstructured":"E.L. Michalets, Update: clinically significant cytochrome P-450 drug interactions. Pharmacotherapy 18(1), 84\u2013112 (1998). https:\/\/doi.org\/10.1002\/j.1875-9114.1998.tb03830.x","journal-title":"Pharmacotherapy"},{"issue":"6494","key":"834_CR22","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1126\/science.aay9189","volume":"368","author":"D Nejman","year":"2020","unstructured":"D. Nejman, I. Livyatan, G. Fuks, N. Gavert, Y. Zwang, L.T. Geller, A. Rotter-Maskowitz, R. Weiser, G. Mallel, E. Gigi, A. Meltser, G.M. Douglas, I. Kamer, V. Gopalakrishnan, T. Dadosh, S. Levin-Zaidman, S. Avnet, T. Atlan, Z.A. Cooper, R. Arora, A.P. Cogdill, M.A.W. Khan, G. Ologun, Y. Bussi, A. Weinberger, M. Lotan-Pompan, O. Golani, G. Perry, M. Rokah, K. Bahar-Shany, E.A. Rozeman, C.U. Blank, A. Ronai, R. Shaoul, A. Amit, T. Dorfman, R. Kremer, Z.R. Cohen, S. Harnof, T. Siegal, E. Yehuda-Shnaidman, E.N. Gal-Yam, H. Shapira, N. Baldini, M.G.I. Langille, A. Ben-Nun, B. Kaufman, A. Nissan, T. Golan, M. Dadiani, K. Levanon, J. Bar, S. Yust-Katz, I. Barshack, D.S. Peeper, D.J. Raz, E. Segal, J.A. Wargo, J. Sandbank, N. Shental, R. Straussman, The human tumor microbiome is composed of tumor type-specific intracellular bacteria. Science 368(6494), 973\u2013980 (2020). https:\/\/doi.org\/10.1126\/science.aay9189","journal-title":"Science"},{"key":"834_CR23","doi-asserted-by":"publisher","unstructured":"L. Palchak, S. Kozlov, C. Melo-Filho et al. Structure-dependent incorporation of terpenes into amphiphilic Poly(2-oxazoline) micelles. Biomed Microdevices 28, 42 (2026). https:\/\/doi.org\/10.1007\/s10544-026-00823-z","DOI":"10.1007\/s10544-026-00823-z"},{"issue":"1","key":"834_CR24","doi-asserted-by":"publisher","first-page":"3259","DOI":"10.1038\/s41467-020-16967-2","volume":"11","author":"L Parhi","year":"2020","unstructured":"L. Parhi, T. Alon-Maimon, A. Sol, D. Nejman, A. Shhadeh, T. Fainsod-Levi, O. Yajuk, B. Isaacson, J. Abed, N. Maalouf, A. Nissan, J. Sandbank, E. Yehuda-Shnaidman, F. Ponath, J. Vogel, O. Mandelboim, Z. Granot, R. Straussman, G. Bachrach, Breast cancer colonization by fusobacterium nucleatum accelerates tumor growth and metastatic progression. Nat. Commun. 11(1), 3259 (2020). https:\/\/doi.org\/10.1038\/s41467-020-16967-2","journal-title":"Nat. Commun."},{"issue":"2","key":"834_CR25","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.bbcan.2019.04.001","volume":"1871","author":"S Parida","year":"2019","unstructured":"S. Parida, D. Sharma, The power of small changes: comprehensive analyses of microbial dysbiosis in breast cancer. Biochim. Biophys. Acta Rev. Cancer 1871(2), 392\u2013405 (2019). https:\/\/doi.org\/10.1016\/j.bbcan.2019.04.001","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"834_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-023-00505-6","author":"S Parida","year":"2023","unstructured":"S. Parida, S. Siddharth, Y. Xia et al. Concomitant analyses of intratumoral microbiota and genomic features reveal distinct racial differences in breast cancer. npj Breast Cancer 9, 4 (2023). https:\/\/doi.org\/10.1038\/s41523-023-00505-6","journal-title":"NPJ Breast Cancer"},{"issue":"1","key":"834_CR27","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1186\/s12964-025-02635-9","volume":"24","author":"S Parida","year":"2026","unstructured":"S. Parida, D. Nandi, D. Verma, M. Yi, A. Yende, J. Queen, K.L. Gabrielson, C.L. Sears, D. Sharma, A pro-carcinogenic oral microbe internalized by breast cancer cells promotes mammary tumorigenesis. Cell Commun. Signal 24(1), 282 (2026). https:\/\/doi.org\/10.1186\/s12964-025-02635-9","journal-title":"Cell Commun. Signal"},{"key":"834_CR28","doi-asserted-by":"publisher","unstructured":"J.K. Patel, A.P. Patel, Passive targeting of nanoparticles to cancer, in Surface Modification of Nanoparticles for Targeted Drug Delivery. ed. by Y.V. Pathak (Springer International Publishing, Cham, 2019), pp.125\u2013143. https:\/\/doi.org\/10.1007\/978-3-030-06115-9_6","DOI":"10.1007\/978-3-030-06115-9_6"},{"issue":"2","key":"834_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9020138","volume":"9","author":"S Rameshbabu","year":"2021","unstructured":"S. Rameshbabu, B.W. Labadie, A. Argulian, A. Patnaik, Targeting innate immunity in cancer therapy. Vaccines 9(2), 138 (2021). https:\/\/doi.org\/10.3390\/vaccines9020138","journal-title":"Vaccines"},{"key":"834_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.cegh.2023.101333","author":"KB Rawal","year":"2023","unstructured":"K.B. Rawal, U.V. Mateti, V. Shetty, M.K. Unnikrishnan, C.S. Shastry. Detection of potential drug-drug interactions among ovarian cancer patients in a tertiary care teaching hospital in South India: A retrospective approach. Clin. Epidemiol. Glob. Health 22, 101333 (2023). https:\/\/doi.org\/10.1016\/j.cegh.2023.101333","journal-title":"Clin. Epidemiol. Glob. Health"},{"issue":"1","key":"834_CR31","doi-asserted-by":"publisher","first-page":"8104","DOI":"10.1101\/2024.02.28.582045","volume":"16","author":"F Sch\u00f6pf","year":"2024","unstructured":"F. Sch\u00f6pf, G.L. Marongiu, K. Milaj, T. Sprink, J. Kikhney, A. Moter, D. Roderer, Structural basis of fusobacterium nucleatum adhesin Fap2 interaction with receptors on cancer and immune cells. Nature Communications 16(1), 8104 (2024). https:\/\/doi.org\/10.1101\/2024.02.28.582045","journal-title":"Nature Communications"},{"issue":"3","key":"834_CR32","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.1021\/nn406388t","volume":"8","author":"A Schulz","year":"2014","unstructured":"A. Schulz, S. Jaksch, R. Schubel, E. Wegener, Z. Di, Y. Han, A. Meister, J. Kressler, A.V. Kabanov, R. Luxenhofer, C.M. Papadakis, R. Jordan, Drug-induced morphology switch in drug delivery systems based on poly(2-oxazoline)s. ACS Nano 8(3), 2686\u20132696 (2014). https:\/\/doi.org\/10.1021\/nn406388t","journal-title":"ACS Nano"},{"issue":"9","key":"834_CR33","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01904-24","volume":"69","author":"I Shahzad","year":"2025","unstructured":"I. Shahzad, M.S. Alasmari, A. Zamir, M.F. Rasool, F. Alqahtani, Clinical pharmacokinetics of metronidazole: a systematic review and meta-analysis. Antimicrob. Agents Chemother. 69(9), e01904-24 (2025). https:\/\/doi.org\/10.1128\/aac.01904-24","journal-title":"Antimicrob. Agents Chemother."},{"issue":"5","key":"834_CR34","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1073\/pnas.94.5.2031","volume":"94","author":"A Sparreboom","year":"1997","unstructured":"A. Sparreboom, J. van Asperen, U. Mayer, A.H. Schinkel, J.W. Smit, D.K.F. Meijer, P. Borst, W.J. Nooijen, J.H. Beijnen, O. van Tellingen, Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine. Proc Natl Acad Sci U S A 94(5), 2031\u20132035 (1997). https:\/\/doi.org\/10.1073\/pnas.94.5.2031","journal-title":"Proc Natl Acad Sci U S A"},{"key":"834_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1144021","author":"MS Thu","year":"2023","unstructured":"M.S. Thu, K. Chotirosniramit, T. Nopsopon, N. Hirankarn, K.\u00a0Pongpirul, Human gut, breast, and oral microbiome in breast cancer: A systematic review and meta-analysis. Front. Oncol. 13, 1144021 (2023). https:\/\/doi.org\/10.3389\/fonc.2023.1144021","journal-title":"Front. Oncol."},{"issue":"4","key":"834_CR36","doi-asserted-by":"publisher","first-page":"299","DOI":"10.37201\/req\/037.2024","volume":"37","author":"A Torrent Rodr\u00edguez","year":"2024","unstructured":"A. Torrent Rodr\u00edguez, A. Font I Barcel\u00f3, M. Barrantes Gonz\u00e1lez, D. Echeverria Esnal, D. Soy Muner, J.A. Mart\u00ednez, M. Tuset Creus, Clinically important pharmacokinetic drug-drug interactions with antibacterial agents. Rev. Esp. Quimioter. 37(4), 299\u2013322 (2024). https:\/\/doi.org\/10.37201\/req\/037.2024","journal-title":"Rev. Esp. Quimioter."},{"issue":"1","key":"834_CR37","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13073-021-00874-2","volume":"13","author":"A Tzeng","year":"2021","unstructured":"A. Tzeng, N. Sangwan, M. Jia, C.-C. Liu, K.S. Keslar, E. Downs-Kelly, R.L. Fairchild, Z. Al-Hilli, S.R. Grobmyer, C. Eng, Human breast microbiome correlates with prognostic features and immunological signatures in breast cancer. Genome Med. 13(1), 60 (2021). https:\/\/doi.org\/10.1186\/s13073-021-00874-2","journal-title":"Genome Med."},{"key":"834_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biomaterials.2018.10.032","volume":"192","author":"X Wan","year":"2019","unstructured":"X. Wan, J.J. Beaudoin, N. Vinod, Y. Min, N. Makita, H. Bludau, R. Jordan, A. Wang, M. Sokolsky, A.V. Kabanov, Co-delivery of paclitaxel and cisplatin in poly(2-oxazoline) polymeric micelles: implications for drug loading, release, pharmacokinetics and outcome of ovarian and breast cancer treatments. Biomaterials 192, 1\u201314 (2019). https:\/\/doi.org\/10.1016\/j.biomaterials.2018.10.032","journal-title":"Biomaterials"},{"issue":"5","key":"834_CR39","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1007\/s13238-020-00813-8","volume":"12","author":"A Wong-Rolle","year":"2021","unstructured":"A. Wong-Rolle, H.K. Wei, C. Zhao, C. Jin, Unexpected guests in the tumor microenvironment: microbiome in cancer. Protein Cell 12(5), 426\u2013435 (2021). https:\/\/doi.org\/10.1007\/s13238-020-00813-8","journal-title":"Protein Cell"},{"issue":"1","key":"834_CR40","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41392-025-02335-3","volume":"11","author":"Y Yao","year":"2026","unstructured":"Y. Yao, Y. Zhu, K. Chen, J. Chen, Y. Li, D. Li, P. Wei, Microbiota in cancer: current understandings and future perspectives. Sig. Transduct. Target Ther. 11(1), 39 (2026). https:\/\/doi.org\/10.1038\/s41392-025-02335-3","journal-title":"Sig. Transduct. Target Ther."},{"issue":"5","key":"834_CR41","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.gendis.2020.08.002","volume":"8","author":"J Zhang","year":"2020","unstructured":"J. Zhang, Y. Xia, J. Sun, Breast and gut microbiome in health and cancer. Genes Dis. 8(5), 581\u2013589 (2020). https:\/\/doi.org\/10.1016\/j.gendis.2020.08.002","journal-title":"Genes Dis."},{"key":"834_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2025.1704489","volume":"16","author":"Y Zhu","year":"2025","unstructured":"Y. Zhu, Y. Li, D. Zeng, N. Li, The risk factors for chemotherapy myelosuppression in breast cancer: a systematic review and meta-analysis. Front. Genet. 16, 1704489 (2025). https:\/\/doi.org\/10.3389\/fgene.2025.1704489","journal-title":"Front. Genet."}],"container-title":["Biomedical Microdevices"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10544-026-00834-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10544-026-00834-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10544-026-00834-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T11:37:41Z","timestamp":1789817861000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10544-026-00834-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,11]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["834"],"URL":"https:\/\/doi.org\/10.1007\/s10544-026-00834-w","relation":{},"ISSN":["1387-2176","1572-8781"],"issn-type":[{"value":"1387-2176","type":"print"},{"value":"1572-8781","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,11]]},"assertion":[{"value":"1 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.V.K. has issued and pending patents related to this work and is a co founder, shareholder, and licensor of technology to DelAQUA Pharmaceuticals, which develops poly(2 oxazoline) micelle formulations.","order":1,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"AI-assisted tools were used to support editing for clarity and conciseness; all scientific content, interpretation, and conclusions were developed and verified by the authors.","order":2,"name":"Ethics","label":"Artificial intelligence disclosure","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"55"}}